vs

Side-by-side financial comparison of Industrial Logistics Properties Trust (ILPT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Industrial Logistics Properties Trust is the larger business by last-quarter revenue ($113.9M vs $83.1M, roughly 1.4× PROCEPT BioRobotics Corp). Industrial Logistics Properties Trust runs the higher net margin — -1.6% vs -38.1%, a 36.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 3.1%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 0.7%).

Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ILPT vs PRCT — Head-to-Head

Bigger by revenue
ILPT
ILPT
1.4× larger
ILPT
$113.9M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+17.1% gap
PRCT
20.2%
3.1%
ILPT
Higher net margin
ILPT
ILPT
36.5% more per $
ILPT
-1.6%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
0.7%
ILPT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ILPT
ILPT
PRCT
PRCT
Revenue
$113.9M
$83.1M
Net Profit
$-1.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
-22.1%
-4.1%
Net Margin
-1.6%
-38.1%
Revenue YoY
3.1%
20.2%
Net Profit YoY
92.6%
-27.9%
EPS (diluted)
$-0.02
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILPT
ILPT
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$113.9M
$76.4M
Q3 25
$110.9M
$83.3M
Q2 25
$112.1M
$79.2M
Q1 25
$111.9M
$69.2M
Q4 24
$110.5M
$68.2M
Q3 24
$108.9M
$58.4M
Q2 24
$110.6M
$53.4M
Net Profit
ILPT
ILPT
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-1.8M
$-29.8M
Q3 25
$-21.6M
$-21.4M
Q2 25
$-21.3M
$-19.6M
Q1 25
$-21.5M
$-24.7M
Q4 24
$-24.1M
$-18.9M
Q3 24
$-25.0M
$-21.0M
Q2 24
$-23.2M
$-25.6M
Gross Margin
ILPT
ILPT
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
ILPT
ILPT
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-22.1%
-40.6%
Q3 25
-29.4%
-27.8%
Q2 25
-30.8%
-28.0%
Q1 25
-26.9%
-39.7%
Q4 24
-31.1%
-28.9%
Q3 24
-33.5%
-38.4%
Q2 24
-32.4%
-50.3%
Net Margin
ILPT
ILPT
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-1.6%
-39.1%
Q3 25
-19.4%
-25.7%
Q2 25
-19.0%
-24.7%
Q1 25
-19.2%
-35.8%
Q4 24
-21.8%
-27.6%
Q3 24
-22.9%
-35.9%
Q2 24
-20.9%
-48.0%
EPS (diluted)
ILPT
ILPT
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.02
$-0.54
Q3 25
$-0.33
$-0.38
Q2 25
$-0.32
$-0.35
Q1 25
$-0.33
$-0.45
Q4 24
$-0.37
$-0.34
Q3 24
$-0.38
$-0.40
Q2 24
$-0.35
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILPT
ILPT
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$94.8M
$245.6M
Total DebtLower is stronger
$4.2B
$51.7M
Stockholders' EquityBook value
$489.7M
$347.7M
Total Assets
$5.2B
$487.1M
Debt / EquityLower = less leverage
8.56×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILPT
ILPT
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$94.8M
$286.5M
Q3 25
$83.2M
$294.3M
Q2 25
$58.6M
$302.7M
Q1 25
$108.0M
$316.2M
Q4 24
$131.7M
$333.7M
Q3 24
$153.9M
$196.8M
Q2 24
$146.2M
$214.1M
Total Debt
ILPT
ILPT
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$4.2B
$51.6M
Q3 25
$4.2B
$51.6M
Q2 25
$4.2B
$51.5M
Q1 25
$4.3B
$51.5M
Q4 24
$4.3B
$51.5M
Q3 24
$4.3B
$51.4M
Q2 24
$4.3B
$51.4M
Stockholders' Equity
ILPT
ILPT
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$489.7M
$365.9M
Q3 25
$494.1M
$380.3M
Q2 25
$519.1M
$385.8M
Q1 25
$539.5M
$389.2M
Q4 24
$562.0M
$402.2M
Q3 24
$585.9M
$241.2M
Q2 24
$618.3M
$251.8M
Total Assets
ILPT
ILPT
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$5.2B
$508.1M
Q3 25
$5.2B
$511.5M
Q2 25
$5.2B
$513.1M
Q1 25
$5.4B
$519.4M
Q4 24
$5.4B
$534.0M
Q3 24
$5.5B
$374.1M
Q2 24
$5.5B
$374.4M
Debt / Equity
ILPT
ILPT
PRCT
PRCT
Q1 26
0.15×
Q4 25
8.56×
0.14×
Q3 25
8.49×
0.14×
Q2 25
8.09×
0.13×
Q1 25
7.96×
0.13×
Q4 24
7.65×
0.13×
Q3 24
7.35×
0.21×
Q2 24
6.96×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILPT
ILPT
PRCT
PRCT
Operating Cash FlowLast quarter
$60.7M
Free Cash FlowOCF − Capex
$42.0M
FCF MarginFCF / Revenue
36.9%
Capex IntensityCapex / Revenue
16.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$79.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILPT
ILPT
PRCT
PRCT
Q1 26
Q4 25
$60.7M
$-10.3M
Q3 25
$22.7M
$-6.6M
Q2 25
$18.4M
$-15.0M
Q1 25
$11.4M
$-17.0M
Q4 24
$2.0M
$-32.4M
Q3 24
$-3.4M
$-18.8M
Q2 24
$10.8M
$-15.7M
Free Cash Flow
ILPT
ILPT
PRCT
PRCT
Q1 26
Q4 25
$42.0M
$-12.2M
Q3 25
$17.6M
$-9.5M
Q2 25
$15.2M
$-17.8M
Q1 25
$5.0M
$-18.8M
Q4 24
$-3.7M
$-33.6M
Q3 24
$-5.9M
$-19.0M
Q2 24
$9.4M
$-16.8M
FCF Margin
ILPT
ILPT
PRCT
PRCT
Q1 26
Q4 25
36.9%
-15.9%
Q3 25
15.9%
-11.4%
Q2 25
13.5%
-22.5%
Q1 25
4.5%
-27.2%
Q4 24
-3.4%
-49.2%
Q3 24
-5.5%
-32.6%
Q2 24
8.5%
-31.4%
Capex Intensity
ILPT
ILPT
PRCT
PRCT
Q1 26
Q4 25
16.4%
2.4%
Q3 25
4.6%
3.4%
Q2 25
2.9%
3.5%
Q1 25
5.7%
2.7%
Q4 24
5.2%
1.7%
Q3 24
2.3%
0.4%
Q2 24
1.3%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILPT
ILPT

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons